← Back to Search

Health Coaching for Inflammatory Bowel Disease

N/A
Waitlist Available
Led By Sara Horst, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial is testing a coaching intervention to improve medication adherence in people with inflammatory bowel disease.

Eligible Conditions
  • Inflammatory Bowel Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medication Adherence MPR
Medication Adherence PDC

Trial Design

2Treatment groups
Experimental Treatment
Group I: Health CoachingExperimental Treatment2 Interventions
Participants in the Health Coaching (HC) arm will be assigned to a health coach for a period of 5 months along with receiving usual care (UC). An initial telephone call with the coach will include a discussion about the participant's self-assessment of health perceptions and goals. This self-assessment creates the foundation for the personalization of the behavioral intervention. From this point, the participant schedules the remaining 9 biweekly sessions (30-45 minute in length), for a total of 10 coaching calls over 5 months. Sociodemographic, behavioral, and psychosocial data will be collected over a period of 24 months by surveys and from the medical record.
Group II: ControlExperimental Treatment1 Intervention
Participants in the control arm will receive usual care (UC). Sociodemographic, behavioral, and psychosocial data will be collected over a period of 24 months by surveys and from the medical record. To enhance recruitment, those subjects randomized to the usual care control group will be offered to participate in the health coaching arm of the study as well after a period of 6 months. If they refuse, they will continue in the usual care control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Coaching
2018
N/A
~1880

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
857 Previous Clinical Trials
672,154 Total Patients Enrolled
AbbVieIndustry Sponsor
958 Previous Clinical Trials
502,341 Total Patients Enrolled
Sara Horst, MDPrincipal InvestigatorVanderbilt University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for participants in this experiment?

"Based on the information available at clinicaltrials.gov, this particular study is no longer recruiting patients; however, 198 other trials are actively seeking candidates as of July 6th 2022. This trial was initially made available to potential participants on June 11th 2019."

Answered by AI
~7 spots leftby Apr 2025